Anti-Human CD30 Recombinant Antibody(Iratumumab)
-
产品编号
YR1162
-
别名
科研级 Iratumumab ( 伊妥木单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Iratumumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Iratumumab ( 伊妥木单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Iratumumab |
| Catalog Number | YR1162 |
| Molecular Name | Iratumumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Iratumumab is a human monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30-positive lymphoma including Hodgkin's disease. This drug was developed by Medarex, which was later acquired by Bristol-Myers Squibb. |
| CAS Number | 640735-09-7 |
| Application | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD30[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
